About Acclinate
Acclinate is a company based in Birmingham (United States) founded in 2020. Acclinate has raised $15.49 million across 6 funding rounds from investors including LabCorp, Cencora and Latimer Ventures. The company has 43 employees as of December 31, 2024. Acclinate offers products and services including HealthSense, e-DICT, and NOWINCLUDED. Acclinate operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Curia and AmplifyBio, among others.
- Headquarter Birmingham, United States
- Employees 43 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Acclinate, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15.49 M (USD)
in 6 rounds
-
Latest Funding Round
$3.5 M (USD), Series A
Feb 11, 2026
-
Investors
LabCorp
& 4 more
-
Employee Count
43
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Acclinate
Acclinate offers a comprehensive portfolio of products and services, including HealthSense, e-DICT, and NOWINCLUDED.
Tracks community health with AI-powered insights for better outcomes.
Measures community engagement using patented technology for insights.
Forges lasting connections to support health equity initiatives.
People of Acclinate
Unlock access to complete
Funding Insights of Acclinate
Acclinate has successfully raised a total of $15.49M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $3.5 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Acclinate
Acclinate has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include LabCorp, Cencora and Latimer Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment partnerships in enterprise SaaS are facilitated by Latimer Ventures.
|
Locked | Locked | Locked | |
|
Early-stage seed funding is provided to Alabama-based startups.
|
Locked | Locked | Locked | |
|
Clinical trial logistics and biopharma outsourcing services are provided globally.
|
Locked | Locked | Locked |
Investor details for Acclinate
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Acclinate
Investment portfolio details for Acclinate
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Acclinate
Detailed financials for Acclinate
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Acclinate Comparisons
Peer comparison for Acclinate
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Acclinate
Acclinate operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Curia and AmplifyBio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| Locked | Locked | Locked |
CDMO offering drug and biologics development services
|
|
| Locked | Locked | Locked |
Selective Wnt agonists are developed for human tissue regeneration.
|
|
| Locked | Locked | Locked |
Drug research, development, testing, and consulting services are provided.
|
|
| Locked | Locked | Locked |
Provides contract research, development, and manufacturing services for biologic drugs.
|
|
| Locked | Locked | Locked |
BGI is engaged in genomics and precision medicine solutions.
|
Detailed competitors of Acclinate
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acclinate
Complete news archive for Acclinate
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acclinate
Acclinate was founded in 2020.
Acclinate is headquartered in Birmingham, United States. It is registered at Birmingham, Alabama, United States.
Acclinate is a funded company, having raised a total of $15.49M across 6 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Acclinate is 43.
Acclinate was founded in 2020 and is headquartered in Birmingham, United States. Clinical trial services are delivered to the biopharma sector, with operations centered on supporting drug development processes. Expertise is applied in trial management, regulatory compliance, and data handling to facilitate efficient clinical research. The company operates within the healthcare and pharmaceuticals industry, serving clients across various therapeutic areas.
Acclinate offers HealthSense, e-DICT, and NOWINCLUDED.
Acclinate has 5 investors. Key investors include LabCorp, Cencora, Latimer Ventures, Alabama Launchpad, and Johnson & Johnson Innovation.